INS and Insulin resistance: The improvement of weight gain and the reduced adiposity after AS93 and PF-BaE11 administration was associated with a slight decrease of fasting glycemia (Figure 3A) and an important reduction in the level of insulin (Figure 3B) and, as such, of the Homeostatic Model Assessment-Insulin Resistance index (HOMA-IR) (Figure 3C) (however, this reduction was not significant).